What are the translational implications of the LEADER trial based on the results reported at ADA 2016?

What are the translational implications of the LEADER trial based on the results reported at ADA 2016?

What are the translational implications of the LEADER trial based on the results reported at ADA 2016?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Richard Pratley, MD

Richard Pratley, MD

Senior Investigator Translational Research Institute for Metabolism and Diabetes Medical Director, Florida Hospital Diabetes Institute (FHDI) Professor, Sanford-Burnham Medical Research Institute at Lake Nona Orlando, Florida